Clinical trial
A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms
NCT00441896 · Marinus Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00441896 |
|---|---|
| Title | A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms |
| Official title | A Double-blind, Placebo-controlled, Dose-ranging Clinical Study to Evaluate the Safety, Tolerability, and Antiepileptic Activity of Ganaxolone in Treatment of Patients With Infantile Spasms |
| Lead sponsor | Marinus Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infantile Spasms |
| Intervention type | Drug, Other |
| Interventions | Ganaxolone, Placebo |
| Enrollment | 57 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 1, 2007 |
| Last update posted | Jun 2, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: